PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 208 filers reported holding PTC THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.07 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $376,807 | -27.1% | 12,322 | -30.6% | 0.00% | – |
Q1 2024 | $516,755 | +7.3% | 17,764 | +1.7% | 0.00% | – |
Q4 2023 | $481,583 | +21.9% | 17,474 | -0.9% | 0.00% | – |
Q3 2023 | $394,954 | -43.9% | 17,624 | +1.9% | 0.00% | – |
Q2 2023 | $703,632 | -18.7% | 17,301 | -3.1% | 0.00% | -100.0% |
Q1 2023 | $864,993 | +25.4% | 17,857 | -1.2% | 0.00% | 0.0% |
Q4 2022 | $689,694 | -22.2% | 18,069 | +2.2% | 0.00% | 0.0% |
Q3 2022 | $887,000 | +29.1% | 17,672 | +3.1% | 0.00% | 0.0% |
Q2 2022 | $687,000 | -11.6% | 17,143 | -17.7% | 0.00% | – |
Q1 2022 | $777,000 | -3.7% | 20,818 | +2.7% | 0.00% | – |
Q4 2021 | $807,000 | -25.1% | 20,275 | -29.9% | 0.00% | -100.0% |
Q3 2021 | $1,077,000 | -6.8% | 28,935 | +5.8% | 0.00% | 0.0% |
Q2 2021 | $1,155,000 | -13.5% | 27,339 | -3.2% | 0.00% | 0.0% |
Q1 2021 | $1,336,000 | -26.1% | 28,229 | -4.7% | 0.00% | 0.0% |
Q4 2020 | $1,809,000 | +72.8% | 29,633 | +32.2% | 0.00% | 0.0% |
Q3 2020 | $1,047,000 | -12.4% | 22,407 | -4.9% | 0.00% | 0.0% |
Q2 2020 | $1,195,000 | +60.0% | 23,552 | +40.6% | 0.00% | 0.0% |
Q1 2020 | $747,000 | -3.2% | 16,752 | +4.1% | 0.00% | 0.0% |
Q4 2019 | $772,000 | +29.5% | 16,086 | -8.7% | 0.00% | 0.0% |
Q3 2019 | $596,000 | -17.0% | 17,610 | +10.2% | 0.00% | 0.0% |
Q2 2019 | $718,000 | -56.4% | 15,973 | -63.4% | 0.00% | -50.0% |
Q1 2019 | $1,645,000 | +13.2% | 43,698 | +3.2% | 0.00% | 0.0% |
Q4 2018 | $1,453,000 | -22.7% | 42,331 | +5.8% | 0.00% | 0.0% |
Q3 2018 | $1,880,000 | +52.1% | 40,000 | +9.2% | 0.00% | +100.0% |
Q2 2018 | $1,236,000 | +62.2% | 36,646 | +30.1% | 0.00% | 0.0% |
Q1 2018 | $762,000 | +86.8% | 28,171 | +15.1% | 0.00% | – |
Q4 2017 | $408,000 | +45.2% | 24,467 | +319.2% | 0.00% | – |
Q2 2015 | $281,000 | +18.1% | 5,836 | +49.0% | 0.00% | – |
Q1 2015 | $238,000 | +16.1% | 3,916 | -1.3% | 0.00% | – |
Q4 2014 | $205,000 | – | 3,967 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Asymmetry Capital Management, L.P. | 110,794 | $3,802,000 | 10.50% |
Boxer Capital, LLC | 2,155,000 | $73,960,000 | 9.14% |
RTW INVESTMENTS, LP | 1,922,346 | $65,975,000 | 6.14% |
GREAT POINT PARTNERS LLC | 1,225,000 | $42,042,000 | 5.31% |
Opaleye Management Inc. | 190,000 | $6,520,000 | 2.43% |
SCOPIA CAPITAL MANAGEMENT LP | 1,626,965 | $55,837,000 | 1.89% |
SPHERA FUNDS MANAGEMENT LTD. | 345,500 | $11,858,000 | 1.34% |
SECTORAL ASSET MANAGEMENT INC | 233,536 | $8,015,000 | 1.09% |
Elk Creek Partners, LLC | 377,674 | $12,962,000 | 1.08% |
Orbimed Advisors | 1,519,700 | $52,156,000 | 0.96% |